Search Results 401-410 of 17325 for Spermatogenesis

1. Obstetrics and Gynecology - Doctors - Mayo Clinic

   Mayo Clinic's Department of Obstetrics and Gynecology offers prevention, diagnosis and treatment for women from childbearing age to menopause and beyond.

2. A Study to Evaluate Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers - Mayo Clinic

   Drugs used in chemotherapy, such as gemcitabine hydrochloride, cisplatin, and nab-paclitaxel, work in different ways to stop the growth of tumor cells, either ...

3. Increasing Activity in Liver Transplant Patients - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

4. A Phase 3 Study to Evaluate Efficacy and Safety of Masitinib in Comparison to Sunitinib in Patients with Gastrointestinal Stromal Tumour After Progression with Imatinib - Mayo Clinic

   A Phase 3 Study to Evaluate Efficacy and Safety of Masitinib in Comparison to Sunitinib in Patients with Gastrointestinal Stromal Tumour After Progression with ...

5. Publications - Bernard J. Kuipers, M.D. - Mayo Clinic

   Butterfield JH, Schwenk NF, Colville D, Kuipers BJ. Severe generalized reactions to ibuprofen. J Rheumatol. 1986; 13:649-650. View PubMed. PST-20222435.

6. Publications - P. Pearse P. Morris, M.B., B.Ch. - Mayo Clinic

   Madhavan AA, Lutzen N, Cutsforth-Gregory JK, Schievink WI, Kodet ML, Mark IT, Morris PP, Messina SA, Wald JT, Brinjikji W. Additional Diagnostic Value of ...

7. Stephen A. Boorjian, M.D. - Doctors and Medical Staff - Mayo Clinic

   He received the Young Urologist of the Year Award from the American Urological Association (AUA) in 2014 and 2018, as well as the 2016 Young Investigator Award ...

8. Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

9. LS1681: A Study of AR160 in Treating Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma - Mayo Clinic

   Drugs used in chemotherapy, such as paclitaxel albumin-stabilized nanoparticle formulation, work in different ways to stop the growth of tumor cells, either by ...

10. Atypical hyperplasia of the breast - Doctors and departments - Mayo Clinic

    Learn how a diagnosis of atypical lobular hyperplasia or atypical ductal hyperplasia affects your risk of breast cancer and what you can do.